MedTrace Logo

Treatment Registry of Arrhythmias, Complications and Electrocardiograms in Arrhythmogenic CardioMyopathies

NCT07688200 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-07-07

No results posted yet for this study

Summary

TRACE-ACM is a multicenter, retrospective, observational study of patients with arrhythmogenic cardiomyopathy who received an implantable cardioverter-defibrillator (ICD) and had documented ventricular tachyarrhythmias. The study aims to describe the prevalence and type of ICD-related complications, characterize ventricular arrhythmias documented by ICD electrograms and/or ECG recordings, and explore associations between clinical, device-related, and treatment-related factors and arrhythmic outcomes.

Conditions

  • Arrhythmogenic Cardiomyopathy (AC, ARVD/C)
  • Ventricular Tachycardia (VT)
  • Ventricular Fibrillation
  • ICD
  • ICD Malfunction
  • ICD SHOCKS
  • Ventricular Arrhythmias and Cardiac Arrest
  • Ventricular Arrhythmia

Sponsors & Collaborators

  • Policlinico Casilino ASL RMB

    lead OTHER

Principal Investigators

  • Luca Barca, MD · Policlinico Casilino, Rome

  • Cinzia Crescenzi, MD · Policlinico Casilino, Rome

  • Kristian Galanti, MD · Policlinico Casilino, Rome

  • Alessandro Nudi, MD · Policlinico Casilino, Rome

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07688200 on ClinicalTrials.gov